Axa
ASTH icon

Axa’s Astrana Health ASTH Stock Holding History

Axa’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-126,614
Closed -$3.15M – 1060
2025
Q2 		$3.15M Buy
+126,614
New +$3.57M 0.01% 663
2023
Q4 		– Sell
-9,300
Closed -$287K – 1142
2023
Q3 		$287K Sell
9,300
-2,900
-24% -$100K ﹤0.01% 988
2023
Q2 		$386K Sell
12,200
-57,650
-83% -$1.98M ﹤0.01% 974
2023
Q1 		$2.55M Buy
69,850
+20,200
+41% +$707K 0.01% 717
2022
Q4 		$1.47M Hold
49,650
– – 0.01% 823
2022
Q3 		$1.94M Buy
49,650
+22,500
+83% +$1.03M 0.01% 763
2022
Q2 		$1.05M Sell
27,150
-10,850
-29% -$413K ﹤0.01% 875
2022
Q1 		$1.84M Buy
38,000
+5,200
+16% +$268K 0.01% 843
2021
Q4 		$2.41M Buy
+32,800
New +$2.69M 0.01% 813

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Axa's ASTH Position: Q3 2025 in Review

Axa sold out of Astrana Health (ASTH) in Q3 2025, closing a stake of 126,614 shares — an estimated $3.15M sold.

Axa first reported a position in ASTH in Q4 2021 and held it in 9 quarters. The position peaked at $3.15M in Q2 2025. 188 funds tracked by Wall St. Rank hold ASTH as of Q3 2025.

  • Axa reported no remaining Astrana Health position as of Q3 2025 after selling out during the quarter.
  • Axa sold 126,614 Astrana Health shares in Q3 2025, an estimated $3.15M.
  • Axa first reported a position in Astrana Health in Q4 2021 and held it in 9 quarters.
  • Axa's Astrana Health position peaked at $3.15M in Q2 2025.
  • 188 funds tracked by Wall St. Rank held Astrana Health as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.